Biosciences
Our researchers in have a rich legacy of collaboration with government agencies and industry partners that improve health outcomes and well-being around the world. SRI Biosciences projects range from high-impact, early-stage research to drug co-development with pharmaceutical and biotech companies.
-
Menopause goes high tech: Understanding your menopause journey by leveraging AI and wearable sensing technology
SRI spinout Lisa Health tackles the menopause gap with AI, digital therapeutics and a new app.
-
SRI International expanding BioCyc database collection for genomic researchers
BioCyc database reaches 20,000 genomes ahead of collaboration with Wolters Kluwer.
-
Scrutinizing a new sleep technology frontier
SRI’s Human Sleep Lab puts consumer wearables to the test.
-
How the COVID-19 pandemic and machine learning delivered insights into adolescent mental health
An ABCD Study® paper delivers insights into the pandemic’s impact on adolescents.
-
SRI International announces collaboration agreement with Janssen
Collaboration focuses on SRI’s Synfini artificial intelligence and automation platform to accelerate small-molecule drug discovery.
-
SRI Bioscience awarded $14.7 million contract to continue development of high-concentration Naloxone formulation
SRI Biosciences has been awarded a contract sponsored by the Defense Threat Reduction Agency (DTRA) to continue development of a high-concentration naloxone product.
-
Automating chemical drug discovery and synthesis
SRI International’s continuous flow SynFini™ Suite produced multiple nucleoside antivirals in a single day.
-
Intracellular delivery—now a reality for many types of therapeutics
Unlocking the therapeutic potential of antisense oglionucleotides and other biologics.
-
Making Distributed Teams More Connected
AI-powered discussion highlights to share knowledge with remote team members.
-
Partnering to Rapidly Advance ZMappTM for Ebola Treatment
SRI scientists partner with Mapp Biopharmaceutical to accelerate FDA approval for clinical trials.
-
HOPO: Partnering to Advance Therapy for Radiation Exposure
SRI scientists collaborate with Lawrence Berkeley National Laboratory to chart a path for obtaining regulatory approval for a clinical development plan for a novel decorporation agent.
-
EcoCyc: Encyclopedia of E. coli genes and metabolism
A bioinformatics database that describes the genome, metabolic network and regulatory network of Escherichia coli.